- ·Watch Axcynsis Therapeutics: the Monday email on marks, rounds and moves
Axcynsis Therapeutics funding history
No funding rounds for Axcynsis Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Axcynsis Therapeutics valuation
Axcynsis Therapeutics's last known valuation is $36.1 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How Axcynsis Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Axcynsis Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Axcynsis Therapeutics
- What is Axcynsis Therapeutics worth?
- Axcynsis Therapeutics's last known valuation is $36.1M.
- How much has Axcynsis Therapeutics raised?
- Axcynsis Therapeutics has raised $21.0M in total funding across its recorded rounds.